Biological Response Modifiers Cmte. Renamed Cellular, Tissue & Gene Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Responsibilities changed to more accurately reflect subject areas commonly addressed by FDA advisory committee. The committee held only one meeting in the last year, added two new members.